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Complete primary stators of both submit of Na’,K+-ATPase from various sources have been ~~biisbed by a ~mbination of the methods 
for molecular cloning and protein chemistry. The gene family homologo~ to the a-subunit cDNA of animal Na+,K*-ATPases has been found 
in the human genome. Some genes of this family encode the known isoforms (aI and aI1) of the Na+,K+-ATPase catalytic subunit. The proteins 
coded by other genes can be either new isoforms of the Na+,K+-ATPase catalytic subunit or other ion-transporting ATPases. Expression of the 
genes of this family proceeds in a tissue-specific manner and changes during the postnatal development and neoplastic transformation. The complete 
exon-intron structure of one of the genes of this family has been established. This gene codes for the form of the catalytic subunit, the existence 
of which has been unknown. Apparently, all the genes of the discovered family have a similar intron-exon structure. There is certain correlation 
between the gene structure and the proposed domain a~angement of the a-subunit. The results obtained have become the basis for the experiments 
which prove the existence of the earlier unknown afI1 isoform of the Na+,K+-ATPase catalytic subunit and have made possible the study of its 
function. 
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1, INTRODUCTION 
Na+,K+-ATPase is a universal enzymatic system in 
animal cell plasma membranes that performs the ATP- 
driven directed transport of sodium and potassium ions 
[ 11. The enzyme releases sodium ions out of the cell and 
pumps potassium ions into the cell. Thus it regulates 
the water-salt composition and m~ntains the ion con- 
centration gradient which, in turn, serves as the motive 
force for transporting other substances. 
Na’,K+-ATPase is involved in generation of electric 
signals and participates in most important biological 
processes. 
That is why, for many years, a lot of effort has been 
put into the study of this enzyme. Biochemic~ and 
kinetic research resulted in postulating the basic ideas 
of the coupling of conformational changes of this en- 
zyme with its cation-transporting functions [2,3]. There 
is, however, no direct proof at the molecular level that 
there exists a relationship between the changes of the 
protein structure and ion transport. Lack of informa- 
tion on the primary structure of the protein and its 
membrane arrangement is a major reason why there oc- 
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curs a gap between the structural and functional 
studies. 
For the last 2-3 years our conception of the 
Na+,K+-ATPase structure has been deepened mainly 
due to the application of molecular cloning and genetic 
engineering techniques. Due to these new approaches a 
lot of structural information has been gained rapidly. 
Fu~hermore, it has made it possible to study not only 
the structural elements of the protein which are in- 
dispensable for its functioning but also the biosynthesis 
of the enzyme subunits and its regulation. The results 
of this research ave contributed to the discovery of 
numerous forms of the Na’,K+-ATPase catalytic 
subunit. This has posed new problems concerning the 
regulation of ion transport. 
Many reviews on different aspects of the 
Na+,K+-ATPase structure and function have appeared 
for the past two years [4-71. Our paper summarizes the 
data on the structure of genes encoding 
Na4,K+-ATPase and considers whether there exists a 
correlation between the structure of these genes and 
that of the protein. 
2. cDNA CLONING AND PROTEIN 
STRUCTURE 
Na’,K+-ATPase belongs to the ElE2 type of 
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transport ATPases which form phospho-derivatives 
of aspartic acid as an intermediate. However, contrary 
to other transport ATPases of the ElE2 type the 
sodium pump consists of two subunits. The catalytic 
subunit (110 kDa) contains all the functional sites of 
the enzyme. Binding sites for ATP and Na+ and the 
phosphorylation site reside in the cytoplasmic region of 
the a-subunit, binding sites for the enzyme inhibitor, 
ouabain, and for potassium ions are located in the 
regions exposed on the other side of the cytoplasmic 
membrane. The P-subunit (relative molecular mass of 
the protein portion 35 kDa) is a glycosylated peptide 
with unknown functions. 
Biochemical studies unravelled two molecular forms 
of the Na+,K+-ATPase catalytic subunit found in 
mammals and arthropods [8-lo]. An exhaustive review 
on this subject can be found in the recent paper by K. 
Sweadner [6]. Here we will discuss this question only 
briefly. 
Two forms of the a-subunit can be distinguished by 
their electrophoretic mobility and sensitivity to cardiac 
glycosides [8]. They were isolated from kidney and ax- 
olemma [8,12]. Besides, the two forms differ in sen- 
sitivity to proteases, cross-linking agents and 
N-ethylmaleimide [8]. The differences in the primary 
structure of the N-terminal fragments [12] and in other 
antigenic determinants of both isoforms have helped to 
isolate the isoform-specific antibodies [ 131. Yet it was 
not clear, why differences occur in the primary struc- 
ture: they might arise either because of the existence of 
several genes for the a-subunit, or because of the post- 
transcriptional modification of the product of the only 
gene (alternative splicing of mRNA), or because of the 
posttranslational modification of the protein product. 
In 1985-1986, cDNAs of the u-subunit of 
Na+,K+-ATPase were cloned from the electric organ of 
Torpedo [ 141 and from the kidney of sheep [ 151 and pig 
[ 161. Soon afterwards, this was followed by the cloning 
of the &subunits from the above mentioned sources 
[ 17- 191. Later some articles have been published on the 
structures of both subunits or only of catalytic subunits 
from some mammals, birds and insects [20-241. These 
structures show a remarkable homology. Even the 
Torpedo and the mammals, which are phylogenetically 
very distant, have homologous a-subunits (85%). 
Homology of a-subunits of different mammals exceeds 
90%. The &subunits from..different sources also have 
a high level of homology (65%), but lower than the a- 
subunits. 
Evidently, the folding of (Y- and P-subunits in the 
membrane is conserved in evolution, as follows from 
the similarity of hydropathy profiles for the subunits 
from different sources. 
The a-subunit polypeptide chain contains eleven 
hydrophobic regions - potential transmembrane do- 
mains. Various models imply the a-subunit polypeptide 
chain to traverse the membrane bilayer 6-8 times 
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[ 14-161. Limited proteolysis of the membrane-bound 
enzyme [25] and immunochemical analysis of the LY- 
subunit topography in the membrane [26] showed that 
the a-subunit polypeptide chain spans the lipid bilayer 
seven times. The location of the N-terminus of the pro- 
tein in the cytoplasmic region of the cell is generally ac- 
cepted [5]. Monospecific antibodies were successfully 
exploited to prove that the C-terminus of the a-subunit 
protrudes into the extracellular space [25,26]. 
However,some investigators suggest that the C- 
terminus has an intracellular location [ 14,151. 
The P-subunit sticks out into the lipid bilayer only 
once so that the major part of the polypeptide chain 
and the C-terminus are exposed outside the cell 
[17,18,27]. 
3. THE FAMILY OF THE GENES FOR THE 
wSUBUNIT 
The early works on cloning of structural genes for 
the a-subunit of mammalian Na+,K+-ATPase were 
carried out with cDNA libraries prepared from kidney 
- an organ containing the largest amount of ATPase. 
Only one sequence was found in the kidney of sheep 
[15] and pigs [16,19]. However, further investigations 
of chromosomal genes for the a-subunit of human 
Na+,K+-ATPase [28,29], as well as of the screening of 
cDNA library from rat brain [30] have led to the 
discovery of the gene family. At present, probably, 
about seven sequences, highly homologous to the gene 
for the a-subunit, were cloned in the human genome 
[29,31]. Out of these genes, three correspond to the 
three mRNAs (aI, ~~11, aIII), found in rat brain which 
code for three isoforms of the enzyme a-subunit [30]. 
One of the genes appeared to be the gene encoding 
H+,K+-ATPase [29,32]. The other genes are not iden- 
tified [29,31]. 
The comparative analysis of amino acid sequences of 
isoforms of Na+,K+-ATPase subunits from different 
sources served to trace their evolution from a common 
precursor [33]. The application of the cluster analysis 
(for algorithm see [34]) allowed construction of a den- 
drogram (fig.1). The results show that the groups of 
very close structures are made up of either human and 
rat &II isoforms, or mammalian and avian cx forms. In 
other words, the related proteins of one species (e.g. 
human (~1 and ~~111 or rat ~1 and aI1) are less 
homologous than the analogous proteins of different 
species. This probably means that the isoforms have a 
very ancient origin. 
The rate of evolutionary substitutions for a site per 
year in the case of the a-subunits is, on average, 0.18 
x 10e9 [28]. The comparison of primary structures of 
human and rat a111 isoforms allows one to evaluate the 
rate of evolutionary substitutions of this isoform (0.06 
x 10m9) [33]. Then making use of the number of 
substitutions between human cy and ~~111 isoforms and 
Volume 257, number 1 FEBS LETTERS October 1989 
Fig. 1. Evolutionary tree of the gene family for the Na+,K+-ATPase 
w-subunit [33]. 
the mean evolutionary rate of these isoforms (0.12 x 
10m9), we can conclude that (Y and crII1 isoforms diverg- 
ed about 650 million years ago. Presumably the (~11 
form appeared somewhat later than a111 (fig.1) [33]. 
A gene for the &I-subunit of Na+,K+-ATPase (al) 
was mapped in the 3rd murine chromosome [35], on the 
2nd mink chromosome [36], and in the short arm of the 
1st human chromosome - Ip21-ten [37]. The gene for 
~11 (cx~) is located in the long arm of the 1st human 
chromosome, region ten-q32, and the gene for ~~111 
@3), in the long arm of the 19th chromosome, 
19q12-q13.2 [37,38]. This form is also localized to 
mouse chromosome 7 [35]. One of the nonidentified 
genes of this family (ATPlALl) is located in the 13th 
human chromosome [37]. The gene for the &subunit is 
mapped in the 13th mink chromosome [39], in the 1st 
mouse chromosome [35] and, presumably, in the long 
arm of the 1 st human chromosome [37]. A homologous 
sequence representing either a P-related gene or 
pseudogene is found on human chromosome 4 [37]. 
Thus, chromosome mapping provides evidence that 
some genes of the a-subunit family are located in dif- 
ferent regions of the first human chromosome, and 
others are distributed in other chromosomes. It is 
noteworthy, that genes for the (~1 and a11 forms of the 
catalytic subunit of the enzyme are located on the first 
chromosome while the gene for the (~111 isoform is 
found on human chromosome 19. 
4. THE STRUCTURE OF THE GENE OF 
~~111 ISOFORM IN CONNECTION WITH 
THE PROTEIN STRUCTURE 
One of the genes belonging to the family of a-subunit 
genes was isolated in four overlapping clones [40,41]. 
The analysis of the primary structure of the exons of 
this gene revealed that it codes for a protein which is 
99% homologous with the a111 isoform of the rat brain 
catalytic subunit [30]. The reconstructed fragment of 
overall size of 30 kb contains the total coding sequence 
[40,41]. It consists of 23 exons separated by 22 introns. 
The comparison of the structure of the chromosomal 
gene and cDNA of the human Na+,K+-ATPase ~111 
isoform shows that the 1st intron is located between the 
2nd and 3rd codons. This location corresponds to the 
separation of the dipeptide MetGly from the rest of the 
molecule. It is noteworthy that in the gene coding for 
a11 isoform the first intron is situated between the 4th 
and 5th codons. This accords with the separation of the 
tetrapeptide MetGlyArgGly [42] from the remaining 
part of the protein. 
Structural features of the Na+,K+-ATPase crII1 gene 
are typical of the majority of eucaryotic genes: exons 
comprise about 10% of the total gene length, their size 
varies within 60-269 bp, whereas the introns con- 
siderably differ in length (70 bp to 6-8 kbp). The struc- 
ture of 3 ‘- and 5 ‘-splice sites coincides with the 
consensus equence described in [43], many introns of 
the ~~111 gene correspond to hydrophilic amino acids 
(table 1, which, in a different way, presents the data 
published in [40]). 
It is interesting to discuss the exon-intron structure of 
the gene for the a111 isoform, taking into consideration 
the secondary structure of the protein and its folding in 
the membrane. Though the protein product of this gene 
has not yet been studied, its calculated secondary struc- 
ture and folding in the membrane are practically the 
same as is the case for the CJ form of the catalytic 
subunit from pig kidney. Fig.2 presents the model for 
the secondary structure of the a-subunit [44]. Arrows 
indicate the position of introns in the a111 gene (intron 
I and N-terminal dipeptide not shown) [40]. 
It was suggested that exons encode transmembrane 
segments of the membrane proteins, whereby introns 
fall into hydrophilic loops between transmembrane LY- 
helices [45]. In eight cases the boundaries of transmem- 
brane domains in cu3 gene coincide with the position of 
the introns (introns 3,4,5,8, 16, 17,20 and 21) (fig.2). 
One should note that there is a certain correlation 
between the location of the introns in the gene and the 
domain organization of the protein in the cytoplasmic 
region. 
The cluster of alternating a-helical and @-pleated 
structures within the Na+,K+-ATPase catalytic site 
deserves pecial attention. Let us compare this enzyme 
with other proteins, which have different functions but 
one common feature: they bind nucleotides as cofac- 
tors. And furthermore, let us look at those proteins, of 
which the secondary structure is known. Such a com- 
parison shows certain structural similarities between 
the nucleotide-binding domains and the genes encoding 
them. Such proteins as alcohol dehydrogenase [46,47], 
glyceraldehydephosphate dehydrogenase 1481, 
phosphoglycerate kinase 1491, pyruvate kinase [50] con- 
tain the nucleotide-binding domains made of six 
parallel B-strands which are connected by cy-helices. 
These domains are distinctly separated from the 
catalytic domains. In most cases, the nucleotide- 
binding domain itself consists of two subdomains. In 
3 
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Table 1 
Splice sites of the cull1 gene of the human Na+,K+-ATPase [40] 
lntron 
number 
Reading frame Sequences in splice site regions 
broken at 
Protein 5 ’ -donor 3 ’ -acceptor 
0 +1 +2 
1 
2 I 
I 
8 
9 ’ I 
10 
11 
12 ’ I 
13 I 
14 
15 ’ 6 I 
17 ’ 8 I 
19 
20 
21 
22 I 
‘1 
MGDK 
AMTE 
VQGL 
DNLY 
PQQA 
CKVD 
VEGTA 
VTVC 
I i%‘Dt 
YQLS 
VLGFC 
I LVI 
1 NPRDA 
RQGA 
EEGRL 
DMVP 
QlGMl 
QWTY 
GMKNK 
PLKPS 
PGGWV 
rintron-L 
GGGG)gtg.. ..tcgcag(G A 
TAT G)gta.. . .cctcag(A C 
GC AG)gtg.. ..ctgtag(G G 
CAAC)gtg.. . .ccacag(C T 
CC AG)gtg.. . .cctcag(C A 
CAAG)gtg.. . .ccccag(G T 
GAAG)gtg.. ..ctgcag(G C 
C AC T )gta.. ..ctccag(G T 
T C AG)gtg.. . .ccccag(G G 
AGAG)gtg.. ..ttgcag(G G 
C C AG)gta.. . .ccccag(C T 
CT T G)gtg.. .cactag(G T 
C AAG)gtg.. .ctgcag(G T 
C C C G)gtg.. . .tcccag(G G 
ACAG)gtg.. . .ccccag(G G 
GAGG)gtg.. .ccacag(G C 
CAT G)gtg.. .gcctag(G T 
ATT G)gtg.. . .ttccag(G A 
GT GG)gtg.. . .ctgcag(A C 
T G A A )gtg ctgcag(G A 
T C AA)&. . .ctgcag(G C 
GGGG)gtg.. .ctccag(G T 
Splice sites consensus equence $$AG)gtg . . .c$ag(G 
Frequence of occurrence of nucleotide (%) 
?i 
2 ;s:g zg 
;z? % 
E 
F 
the genes of these proteins the nucleotide-binding do- 
mains are encoded by several exons, the introns tend to 
fall into gaps between certain cu/fi segments or their 
pairs. The presence of the intron, which separates the 
catalytic and nucleotide-binding domains, is 
characteristic of the genes of this type of proteins. 
Fig.2 shows that in the case of Na+,K+-ATPase the 
nucleotide-binding domain identified by affinity 
modification [53-551 also accommodates two clusters 
of alternating cu/fi structures with three P-pleated 
regions in-between. All of the domain is encoded by six 
whole exons (10-15) and by the beginning of the 
seventh (16th) exon. The aspartic acid residue 
phosphorylated reversibly during the action of the en- 
zyme points to the position of the catalytic domain. 
The function of the intron located between the catalytic 
and nucleotide-binding domain can be fulfilled by the 
intron 9. The introns 12 or 13 can be considered to be 
analogs of introns which divide the nucleotide-binding 
domain into two subdomains. 
Another approach focuses on revealing the 
regularities in the primary structure of nucleotide- 
binding domains [5 11. This approach helped to identify 
the consensus equences in the case of Na+,K+-ATPase 
4 
[40]. The structure of peptides 242-270 and 710-744 
accords well with the sequences of sites A and B, which 
are involved in the ATP binding, according to Walker 
et al. [52]. Moreover, in these domains there are the 
characteristic elements of the secondary structure. 
These elements are the ,Ha or cu/fl/cu regions [5 11. The 
direct participation of fragment 710-744 of 
Na+,K+-ATPase a-subunit in the ATP binding was 
shown by affinity labelling [53-551. Thus, according to 
these data the nucleotide-binding site of 
Na+,K+-ATPase is formed of two domains, which are 
separated in the primary structure but spatially prox- 
imated. 
Both peptides are highly homologous with the cor- 
responding regions of Ca-ATPase of sarcoplasmic 
reticulum [56]. The genes for both proteins have the 
similar exon-intron structure in the regions, which cor- 
respond to these fragments. Peptide 242-270 in both 
proteins is encoded by exon 8, positions of intron boun- 
daries differing only by 19 and 20 nucleotides. The 
boundaries of the next exon 9, which codes for the most 
conserved region including the phosphorylation site in 
both ATPases, is shifted only by 50 nucleotides in Ca- 
ATPase as compared to Na+,K+-ATPase. The second 
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Fig.2. Model for membrane arrangement of the Na+,K+-ATPase catalytic subunit. Cylinder and arrows indicate a-helical and B-sheeted regions. 
Arrows with figures indicate positions and numbers of introns in the gene for the human (rII1 isoform. Amino acid residues D-369, K-501, D-714, 
and K-719 enter the enzyme active site. The model of &subunit is indicated on the right [40&t]. 
region (peptide 710-714) in both proteins is encoded by 
the beginning of the 16th exon, positions of the cor- 
responding introns differing by 18 nucleotides. 
Thus, it is not only possible to find homologous pep- 
tides in ATPases of ElEZtype of different specificity 
but also to find some analogies in the structure of genes 
encoding them. The complete exon-intron structure of 
other genes of Na+,K+-ATPase catalytic subunit family 
is unknown, but the data on the partial structure of 
some genes of this family [29] imply that all the genes 
have a similar intron location. These data support the 
hypothesis on the existence of a common ancestor gene 
of transport ATPases which duplicated and diverged 
during evolution into various forms of different 
specificity. Moreover, some analogies in the organiza- 
tion of nucleotide-binding domains of proteins which 
fulfill very different functions and analogies in the 
organization of corresponding genes can be considered 
to support the Gilbert and Black hypothesis, which 
pointed out that exons corresponded to units of discreet 
protein structure and/or function and that proteins had 
evolved by the combination of domains carrying par- 
ticular functions [57,58]. 
5. TISSUE-SPECIFICITY OF EXPRESSION OF 
VARIOUS ISOFORMS OF Na+,K+-ATPase 
CATALYTIC SUBUNIT 
Tissue-specific distribution of two forms of a- 
subunit of Na+,K+-ATPase has been shown earlier, 
e.g. a-form was found predominantly in mammalian 
kidney and the mixture of a and (Y+ forms, in brain 
[8,13]. For detailed review see [6]. However, the 
discovery of the third isoform with the affinities for 
substrates and inhibitors first unknown complicated 
the interpretation of the earlier results obtained by im- 
munochemical methods. For instance, the a+ isoform 
discovered in rat brain is now believed to be a mixture 
of cvI1 and a111 isoforms [6,59]. 
The Northern blotting allows one to study the steady- 
state concentration of mRNA in different tissues, 
however it says nothing about the mechanisms 
operating on translational or posttranslational evel. 
Therefore, the combination of Northern blots with im- 
munochemical methods using isoform-specific an- 
tibodies will be most informative. 
The contents of mRNA of various forms of the 
catalytic subunit in mammalian tissues were in- 
vestigated in several laboratories by means of gene- 
specific probes [60-631. 
The cul mRNA, 3.7 kb, was discovered in virtually 
all rat and human tissues investigated [60-631. The 
largest amounts were found in kidney, the smallest in 
liver. Two or even three (r2 mRNAs (5.3-6, 3.4-4.5 
and 2.4 kb) were found in different amounts in many 
rat tissues except for liver [61,62,64,65]. This variety 
could result from the differential use of the 
polyadenylation signals in the 3 ‘-untranslated region of 
cu2 mRNA [61]. But one cannot rule out some cross- 
hybridization due to the high level of homology of dif- 
ferent isoforms especially when large cDNA probes 
have been used [64,65]. Both main mRNAs of aI1 form 
have been shown to be expressed in brain, skeletal 
muscles and heart [61]. 
The 1x3 mRNA, 3.7 kb, was detected in rat brain, 
stomach and lung [61]. Hybridization with mRNA 
from human tissues demonstrated the presence of the 
~111 isoform in kidney, brain and thyroid gland [60]. 
The presence of the cu3 mRNA in human kidney and its 
absence in rat kidney can be a result of drug ad- 
ministration in humans or of some other factors. This 
question deserves pecial attention and could be solved 
when the statistically reliable material is available. In 
situ mapping of rat brain areas suggests that (~3 mRNA 
of Na+,K+-ATPase is expressed predominantly by 
neural cells [66]. 
Application of gene-specific probes made possible 
the study of distribution of isoform-specific mRNAs 
5 
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during ontogenesis. The level of mRNAs of three 
isozymes of Na+,K+-ATPase and @subunit in rat 
brain, heart, lung, kidney and skeletal muscles during 
the development was investigated by Orlowsky and 
Lingrel [59]. The cy forms and &subunit mRNAs ap- 
pear to be regulated coordinately during ontogenesis 
with maximum expression occurring between 15 and 25 
days old for brain, heart, kidney and skeletal muscle. 
The peak of expression in lung was shown to be bet- 
ween 2 and 4 days of neonatal life [59]. 
Expression of the (~1 and &II isoforms in infant and 
adult human brain and kidney tissues increased as com- 
pared with embryonic tissues [60]. These data correlate 
well with the results on rat brain Na+,K+-ATPase ac- 
tivity which also has been shown to increase from pre- 
to postnatal state [67]. Increasing activity of 
Na+,K’-ATPase during the postnat~ development was 
observed also on rat subm~illary glands 1681, rabbit 
hippocampus 1691. However, only now the study of ex- 
pression of certain a-subunit isoforms became possible. 
No doubt research into the tissue-specific expression 
of different forms of Na+,K+-ATPases will be extend- 
ed to tissues in pathology. So, e.g. the expression level 
of the a11 and cuIII-isoforms decreased in rats in 
response to increased intravascular pressure, at the 
same time the correlated enhancement in expression of 
the crI form and J-subunit of Na+,K+-ATPase was 
observed [70]. 
The discovery of a family of catalytic subunit genes 
suggests that the functional diversity of 
Na+,K+-ATPase activity in different tissues and cells 
can be attributed to different properties of individual 
isoforms. The problem becomes especially exciting in 
connection with tissue specificity and developments 
regulation of the expression of these isoforms. Dif- 
ferent sensitivity of the known isoforms of 
Na+,K+-ATPase to their inhibitor, ouabain, gives a 
hint of their possible role. The distinct relative contents 
of isoforms in the cells of different tissues lead to 
varied sensitivity of these cells to the inhibitor. Let us 
assume the existence of endogenic inhibitors and ac- 
tivators of Na+,K’-ATPase, which differently act on 
different isoforms. Then the fine-tuned physiological 
mechanism of dissimilar response of different tissues to 
the same changes under the conditions of the increase 
(or decrease) of the inhibitor (or activator) contents in 
the intercellular medium should operate. The en- 
dogenic inhibitor of Na+,K+-ATPase with biological 
properties analogous to those of ouabain has been 
recently shown to exist [71]. Other potential endogenic 
regulators of the enzyme were mentioned (for review 
see 1721). 
The study of functional properties of each isoform 
should deepen the knowledge already gained. The study 
of the characteristics of the a1 and (~11 isoforms was 
started some years ago [6,8]. As to the ~~111 form one 
should first of all prove its existence. The knowledge of 
6 
deduced primary and calculated secondary structures 
of the protein promotes the choice of potential im- 
munogenic peptides, their synthesis and preparation of 
the antibodies monospecific for this type of the protein. 
Use was made of this approach to unravel the ~~111 
isoform of the catalytic subunit in the human brain 
preparation and in pig and human kidney [73]. Its N- 
terminal sequence jet-Gly-Asp-Lys-Lys-Asp-Asp 
completely corresponds to the structure of the a3 gene 
[40]. Thus, unlike tu1 and atI1, the a111 protein is not 
subjected to posttranslational processing in the N- 
terminal region. The (~111 isoform has the highest sen- 
sitivity to ouabain as compared to other isoforms [74]. 
This was revealed by the analysis of ouabain sensitivity 
of the rat brainstem axolemma membrane containing 
only the ~~111 isoform. These prep~ations of the mem- 
brane were obtained using limited trypsin digestion of 
brainstem axolemma. Such treatment selectively 
removes the cvI1 isoform [74]. A high level of ouabain 
sensitivity was also shown for the product of expression 
of cDNA of the rat brain (~111 isoform in Balb/c 3T3 
cells [75]. 
Thus, the example of the (rIII rsoform of the catalytic 
subunit shows the progress in our knowledge of 
Na+,K+-ATPase. This progress was achieved due to the 
use of the methods of molecular cloning, which allowed 
one to isolate a gene for a new isoform of the catalytic 
subunit. The knowledge of its primary structure helped 
to prove the existence of a new protein in human brain 
and pig and human kidney [73]. One cannot exclude 
that other genes of this gene family will be identified as 
genes coding for new isoforms or for other ATPases 
with different specificity. 
6. ON REGULATION OF EXPRESSION OF 
GENES FOR Na+,K+-ATPase 
The study of mechanisms of tissue-specificity and 
developmental regulation of gene expression is a major 
problem of modern molecular biology. The tissue- 
specific regulation at the transcriptional level is best 
studied. It occurs due to direct or indirect interaction of 
specific cellular factors with the regulatory c&-elements 
of DNA located in promoters and enhancers. Unfor- 
tunately, the regulatory elements of genes for 
Na+,K*-ATPase isoforms are unknown, The only 
work concerning this problem determines the primary 
structure of about 1400 bp preceding the gene for the 
human (~11 isoform [42]. 
The hypothetical transcription starting point in the 
ru2 gene is situated at about lot) bp upstream to the in- 
itiation ATG codon where the pyrimidine-rich cluster 
has been found [42]. At a distance of about 30 bp from 
this site the imperfect TATA box is located, its struc- 
ture resembles that of analogous sites of other genes, 
e.g. genes for murine kallikrein, for human cy- 
interferon, for Rous sarcoma virus and virus AAV2 
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(for review see 1761). The TATA box is not the only 
region homologous to other genes. In the regulatory 
region of the gene for (~11 isoform there is a double 
repeat of oligonucleotide GGGGGAGA. Closely 
homologous sequences in analogous regions are found 
in other genes, e.g. gene for Ca-ATPase [56], gene for 
serine protease from human bone marrow [77]. A 
homologous sequence in opposite orientation is 
discovered in the enhancer of W-40 and its significance 
for the enhancer function is shown [78]. 
Some eukaryotic promoters contain the CCAAT 
conserved sequence in position - 80, The a2 gene con- 
tains in this region the CAACAAAC structure flanked 
by tetranucleotides GTTT [42]. The region - 120 in- 
volves hexanucleotide GGGCCG, which binds factor 
Spl [79]. The putative regulatory region of the a2 gene 
contains many oligo-G blocks 1421. 
The structural analysis of other regulatory elements, 
their comparison, identification of specific cell factors 
interacting with them is a way of comprehending the 
tissue-specific expression of members of a gene family 
coding for different isoforms of the Na+,K+-ATPase 
catalytic subunit. 
7. THE FAMILY OF ~-SUBUNIT GENES 
Biochemical investigations on Na+,K+-ATPase gave 
birth to the hypothesis that the P-subunit is an integral 
component of the enzyme. Several lines of evidence 
show that Na+,K+-ATPase (Y- and P-subunit synthesis 
is coordinately regulated and both subunits are express- 
ed at approximately equal levels [64,65,80-821. 
Several questions arise from the discovery of multi- 
ple forms of the a-subunit. First, whether heterogeneity 
of the&subunits exists at the protein level, apart from 
the heterogeneity of glycosylation. &Subunit mRNAs 
from different sources (Torpedo [17], sheep, pig, dog 
and chicken [18,19,22,23], human HeLa cells [20], rat 
[21,83]) are cloned. In each case only the coding se- 
quence was found. The mammalian P-subunit genes 
show high level of homology (90070). However, more 
detailed analysis of rat kidney and brain unravelled 
several species of mRNA with similar coding regions 
and differing in length of 3 ’ - and 5 ‘-untranslated 
regions [83]. Size variations at the 3 ’ -end occur due to 
the use of different polyadenylation sites. Differenti~ 
utilization of the sites of transcription initiation, which 
is specific for certain tissues, is a characteristic feature 
of the P-subunit mRNA. In kidney, muscles and 
stomach the longer mRNA is synthesized, and in brain 
the shorter one [83]. 
The second question is, whether each type of cy- 
subunit is bound to the specific type of &subunit or dif- 
ferent a-subunits can interact with the same P-protein. 
This question remains to be answered. At present we 
only know the relative amounts of mRNAs for dif- 
ferent a-subunits and the only &subunit. In some 
tissues (kidney, brain, heart) the coordinated expres- 
sion of three LY forms and ~-subunit can be proposed, 
in others (muscle, stomach) it seems impossible [83]. 
Orlowsky and Lingrel found the coordinated regulation 
of LY isoforms and P-subunit during ontogenesis 1591. 
The recent publication of Martin-Vasallo et al. [84] 
claimed to discover in rat brain and human liver an 
mRNA homologous to the mRNA of the &subunit of 
Na”,K+-ATPase, homology level being 58%. This gene 
was designated as ,&2 gene. The expression of this gene 
proceeds in a tissue-specific manner but distinct from 
that for the ~-subunit gene [84]. Keeping in mind the 
relatively low level of homology between @I and ,&2 
genes one cannot exclude that ,6’2 protein is a compo- 
nent of another ion-transporting ATPase. Such a 
subunit was suggested to be a component of 
H+,K’-ATPase [85]. 
The discovery of a second type of &subunit leads to 
the conclusion, that a family of P-subunit genes exists. 
In fact, when analysing a human genomic library using 
pig kidney cDNA of the P-subunit as a hybridization 
probe Ushkaryiov et al. found at least two different se- 
quences [86]. One sequence presents most probably the 
gene coding for P-subunit, the isolated fragment con- 
tains one exon coding for the putative transmembrane 
segment and two introns. Their location correlates with 
boundaries of transmembrane domain of the P-subunit 
1861. The second sequence highly homologous to the pl 
gene, is intron free and contains many stop codons, and 
an insert. Therefore it was proposed that this sequence 
is a pseudogene belonging to the b-subunit family [86]. 
8. CONCLUSION 
Structural analysis of Na+,K+-ATPase genes, 
discovery of multiple isoforms responding differently 
to the action of inhibitors and determination of tissue- 
specificity of gene expression open new horizons for in- 
vestigators involved in problems of physiologic~ ion 
transport and for those who treat different disorders of 
water-salt exchange and cardiovascular diseases. 
Multiplicity of isoforms underlies the strategy of dif- 
ferential action on organs and tissues by means of 
specific inhibitors or activators of one or another 
isoform. Further research into the regulation of gene 
expression, into the role of isoforms, search of new 
isoforms will provide a deeper understanding of ion 
transport in the functioning of eucaryotic cell. 
Acknowledgements: We wish to thank Dr V.M. Gindilis for help in 
calculations of evolutionary trees. We are grateful to many colleagues 
for participation in experiments and discussions. 
REFERENCES 
fl] Glynn, I.M. (1985) in: The Enzymes of Biological Membranes, 
vol.3 (Martonosi, A.N. ed.) pp.35184, Plenum, New York. 
7 
Volume 257, number 1 FEBS LETTERS October 1989 
[2] Jorgensen, P.L. (1982) Biochim. Biophys. Acta 694, 27-68. 
[3] Karlish, S.J.D. and Stein, W.D. (1982) Ann. NY Acad. Sci. 
226-238. 
141 Fambrough, D.M. (1988) Trends Neurosci. 8, 325-328. 
[5] Jorgensen, P.L. and Andersen, J.P. (1988) J. Membr. Biol. 
103, 95-120. 
[6] Sweadner, K.J. (1989) Biochim. Biophys. Acta 988, 185-220. 
[7] Rossier, B.C., Geering, K. and Kraehenbuhl, J.P. (1987) 
Trends Biol. Sci. 12, 483-487. 
[8] Sweadner, K.J. (1979) J. Biol. Chem. 254, 6060-6067. 
[9] Peterson, G.L., Ewing, R.D., Hootman, S.R. and Conte, F.P. 
(1978) J. Biol. Chem. 253, 4762-4770. 
[lo] Peterson, G.L. and Hokin, L.E. (1981) J. Biol. Chem. 256, 
3751-3761. 
[ll] Sweadner, K.J. (1985) J. Biol. Chem. 260, 11508-11513. 
[12] Lytton, J. (1985) Biochem. Biophys. Res. Commun. 132, 
764-769. 
[13] Sweadner, K.J. and Gilkeson, R.C. (1985) J. Biol. Chem. 260, 
9016-9022. 
[14] Kawakami, K., Noguchi, S., Noda, M., Takahashi, H., Ohta, 
T., Kawamura, M., Nojima, H., Nagano, K., Hirose, T., 
Inayama, S., Hayashida, H., Miyata, T. and Numa, S. (1985) 
Nature 316, 733-736. 
115) Shull, G.E., Schwartz, A. and Lingrel, J.B. (1985) Nature 316, 
691-695. 
[16] Ovchinnikov, Yu.A., Arsenyan, S.G., Broude, N.E., 
Petrukhin, K.E., Grishin, A.V., Aldanova, N.A., 
Arzamazova, N.M., Arystarkhova, E.A., Melkov, A.M., 
Smirnov, Yu.V., Guryev, SO., Monastyrskaya, G.S. and 
Modyanov, N.N. (1985) Dokl. Akad. Nauk SSSR 235, 
1490-1495. 
[17] Noguchi, S., Noda, N., Takahashi, H., Kawakami, R., Ohta, 
T., Nagano, K., Hirose, T., Inayama, S., Kawamura, M. and 
Numa, S. (1986) FEBS Lett. 196, 315-320. 
[18] Shull, G.E., Lane, L.K. and Lingrel, J.B. (1986) Nature 321, 
429-43 1. 
[ 191 Ovchinnikov, Yu.A., Modyanov, N.N., Broude, N., 
Petrukhin, K.E., Grishin, A.V., Arzamazova, N.M., 
Aldanova, N.A., Monastyrskaya, G.S. and Sverdlov, E.D. 
(1986) FEBS Lett. 201, 237-245. 
[20] Kawakami, K., Nojima, H., Ohta, T. and Nagano, K. (1986) 
Nucleic Acids Res. 14, 2833-2844. 
[21] Mercer, R.W., Schneider, J.W., Savitz, A., Emanuel, J., Benz, 
E.J. and Levenson, R. (1986) Mol. Cell. Biol. 6, 3884-3890. 
[22] Takeyasu, K., Tamkun, M.M., Siegel, N.R. and Fambrough, 
D.M. (1987) J. Biol. Chem. 262, 10733-10740. 
[23] Brown, T.A., Horowitz, B., Miller, R.P., McDonough, A.A. 
and Farley, R.A. (1987) Biochim. Biophys. Acta 912, 244-253. 
[24] Lebovitz, R.M., Takeyasu, K. and Fambrough, D.M. (1989) 
EMBO J. 8, 193-202. 
125) Ovchinnikov, Yu.A., Arzamazova, M., Arystarkhova, E.A., 
Gevondyan, N.M., Aldanova, N.A. and Modyanov, N.N. 
(1987) FEBS Lett. 217, 269-274. 
[26] Ovchinnikov, Yu.A., Luneva, N.M., Arystarkhova, E.A., 
Gevondyan, N.M., Kozhich, A.T., Nesmeyanov, V.A. and 
Modyanov, N.N. (1988) FEBS Lett. 227, 230-234. 
[27] Ovchinnikov, Yu.A. (1987) Trends Biol. Sci. 12, 434-438. 
[28] Ovchinnikov, Yu.A., Monastyrskaya, G., Broude, N.E., 
Allikmets, R.L., Ushkaryov, Yu.A., Melkov, A.M., Smirnov, 
Yu.V., Malyshev, I.V., Dulubova, I.E., Petrukhin, K.E., 
Grishin, A.V., Sverdlov, V.E., Kiyatkin, N.I., Kostina, M.B. 
and Modyanov, N.N. (1987) FEBS Lett. 213, 73-80. 
[29] Sverdlov, E.D., Monastyrskaya, G.S., Broude, N.E., 
Ushkaryov, Yu.A., Allikmets, R., Melkov, A.M., Smirnov, 
Yu.V., Malyshev, I.V., Dulubova, I.E., Petrukhin, K.E., 
Grishin, A.V., Kiyatkin, N.I., Kostina, M.B., Sverdlov, V.E., 
Modyanov, N.N. and Ovchinnikov, Yu.A. (1987) FEBS Lett. 
217, 275-278. 
[30] Shull, G.E., Greeb, J. and Lingrel, J.B. (1986) Biochemistry 
25, 8125-8132. 
8 
[31] Shull, M.M. and Lingrel, J.B. (1987) Proc. Natl. Acad. Sci. 
USA 84, 4039-4043. 
[32] Shull, G.E. and Lingrel, J.B. (1986) J. Biol. Chem. 261, 
16788-16791. 
[33] Broude, N.E., Gindilis, V.M. and Sverdlov, E.D., in 
preparation. 
[34] Alexandrov, V.V. and Gorsky, N.D. (1983) in: Algorithms and 
Programs for Analysis of Structural Data, p.58, Leningrad, 
Nauka. 
[35] Kent, P.A., Fallows, ‘D., Geissler, E., Glaser, T., Emanuel, 
J.R., Lalley, P.A., Levenson, R. and Housman, D.E. (1987) 
Proc. Natl. Acad. Sci. USA 84, 5369-5373. 
[36] Matveeva, N.M., Khlebodarova, T.M., Karasik, G.T., 
Rubtzov, N.B., Serov, O.L., Sverdlov, E.D., Broude, N.E., 
Modyanov, N.N., Monastyrskaya, G.S. and Ovchinnikov, 
Yu.A. (1987) FEBS Lett. 217, 42-44. 
[37] Yang-Feng, T.L., Schneider, J.W., Lindgren, V., Shull, M.M., 
Benz, E.J., Lingrel, J.B. and Francke, U. (1988) Genomics 2, 
128-138. 
[38] Harley, H.G., Brook, J.D., Jackson, C.L., Glaser, T., Walsh, 
K.V., Sarfarpzi, M., Kent, R., Lager, M., Koch, M., Harper, 
P.S., Levenson, R., Housman, D.E. and Show, D.J. (1988) 
Genomics 3, 380-384. 
[39] Khlebodarova, T.M., Karasik, G.I., Lapteva, S.E., Matveeva, 
N.M., Serov, O.L., Sverdlov, E.D., Broude, N.E., Modyanov, 
N.N. and Monastyrskaya, G.S. (1988) FEBS Lett. 236, 
240-242. 
[40] Ovchinnikov, Yu.A., Monastyrskaya, G.S., Broude, N.E., 
Ushkaryov, Yu.A., Melkov, A.M., Smirnov, Yu.V., Malyshev, 
I.V., Allikmets, R.L., Kostina, M.B., Dulubova, I.E., 
Kiyatkin, N.I., Grishin, A.V., Modyanov, N.N. and Sverdlov, 
E.D. (1988) FEBS Lett. 233, 87-94. 
[41] Sverdlov, E.D., Monastyrskaya, G.S., Broude, N.E., 
Ushkaryov, Yu.A., Melkov, A.M., Orlova, M.A., Malyshev, 
I.V., Modyanov, N.N., in preparation. 
[42] Sverdlov, E.D., Bessarab, D.A., Malyshev, I.V., Smirnov, 
Yu.V., Ushkaryov, Yu.A., Monastyrskaya, G.S., Broude, 
N.E. and Modyanov, N.N. (1989) FEBS Lett. 244, 481-483. 
[43] Patget, R.A., Grabovski, P. J., Konarska, M.M., Seiler, S. and 
Sharp, P.A. (1986) Annu. Rev. Biochem. 55, 1119-1150. 
[44] Ovchinnikov, Yu.A., Arystarkhova, E.A., Arzamazova, N.M., 
Dzhandzhugazyan, K.N., Efremov, R.G., Nabiev, I.R. and 
Modyanov, N.N. (1988) FEBS Lett. 227, 235-239. 
[45] Nathans, J. and Hogness, D.S. (1984) Proc. Natl. Acad. Sci. 
USA 81, 4851-4855. 
[46] Duester, G., Jornvall, H. and Hatfield, G.W. (1986) Nucleic 
Acids Res. 14, 1931-1941. 
[47] Branden, C.-I., Eklund, H., Cambillau and Prior, A.J. (1984) 
EMBO J. 3, 1307-1310. 
[48] Stone, E.M., Rothblum, R.N. and Schwartz, R.J. (1985) 
Nature 313, 498-500. 
[49] Michelson, A.M., Blake, C.C.F., Evans, S.T. and Orkin, S.H. 
(1985) Proc. Natl. Acad. Sci. USA 82, 6965-6969. 
[50] Lonberg, N. and Gilbert, W. (1985) Cell 40, 81-90. 
[51] Fothergill-Gilmore, L.A. (1986) in: Multidomain Proteins - 
Structure and Evolution (Hardie, D.G. and Coggins, J.R. eds) 
pp.85-174, Elsevier, Amsterdam. 
[52] Walker, J.E., Saraste, M., Ruswick, M.Y. and Gay, M.J. 
(1982) EMBO J. 1, 945-951. 
[53] Dzhandzhugazyan, K.N., Lutsenko, S.V. and Modyanov, N.N. 
(1986) Biol. Membr. 3, 858-868. 
[54] Ovchinnikov, Yu.A., Dzhandzhugazyan, K.N., Lutsenko, 
S.V., Mustaev, A.A. and Modyanov, N.N. (1987) FEBS Lett. 
217, 111-116. 
[55] Nagano, K., Ohta, T. and Yoshida, M. (1986) Proc. Natl. 
Acad. Sci. USA 83, 2071-2075. 
[56] Korczak, B., Zarain-Herzberg, A., Brandl, C.J., Ingles, C.J., 
Green, N.M. and MacLennan, D.H. (1988) J. Biol. Chem. 263, 
4813-4819. 
[57] Gilbert, W. (1978) Nature 271, 501. 
Volume 257, number 1 FEBS LETTERS October 1989 
[58] Blake, C.C.F. (1983) Nature 306, 535-537. 
[59] Orlowsky, J. and Lingrel, J.B. (1988) J. Biol. Chem. 263, 
10436-10442. 
[60] Sverdlov, E.D., Broude, N.E., Sverdlov, V.E., Monastyrskaya, 
G.S., Petrukhin, K.E., Akopyanz, N.S., Modyanov, N.N. and 
Ovchinnikov, Yu.A. (1987) FEBS Lett. 221, 129-133. 
[61] Young, R.M. and Lingrel, J.B. (1987) Biochem. Biophys. Res. 
Commun. 145, 52-58. 
[62] Herrera, V.L., Emanuel, J.R., Ruiz-Opazo, N., Levenson, R. 
and Nadal-Ginard (1987) J. Cell. Biol. 105, 1855-1864. 
[63] Sverdlov, E.D., Akopyanz, N.S., Petrukhin, E.R., Broude, 
N.E., Monastyrskaya, G.S. and Modyanov, N.N. (1988) FEBS 
Lett. 239, 65-68. 
[64] Emanuel, J.R., Garetz, S., Schneider, J., Ash, J.F., Benz, 
E.J.J. and Levenson, R. (1986) Mol. Cell. Biol. 62,2476-2481. 
[65] Emanuel, J.R., Garetz, S., Stone, L. and Levenson, R. (1987) 
Proc. Natl. Acad. Sci. USA 84, 9030-9034. 
[66] Schneider, J.W., Mercer, R.W., Gilmore-Hebert, M., Utset, 
M.F., Lai, C., Greene, A. and Benz, E.J., jr (1988) Proc. Natl. 
Acad. Sci. USA 85, 284-288. 
[67] Schmitt, C.A. and McDonough (1986) J. Biol. Chem. 261, 
10439-10444. 
[68] Camden, J. and Martinez, J.R. (1987) Experientia 43,570-572. 
[69] Haglund, M.M., Stahl, W.L., Kunkel, D.D. and 
Schwartzkroin, P.A. (1985) Brain Res. 343, 198-203. 
[70] Herrera, V.L.M., Chobanian, A.V. and Ruiz-Opazo, N. (1988) 
Science 4862, 222-223. 
[71] Tamura, M., Tim-Tak Lam and Inagami, T. (1988) 
Biochemistry 27, 4244-4253. 
[72] Haupert, G.T., jr in: The Na+,K+-Pump, Part B: Cellular 
Aspects (Skou, J.C. et al. eds) pp.297-320, Alan R. Liss, New 
York. 
[73] Arystarkhova, E.A., Lakhtina, O.E. and Modyanov, N.N. 
(1989) FEBS Lett., in press. 
[74] Urayama, 0. and Sweadner, K.J. (1988) Biochem. Biophys. 
Res. Commun. 156, 796-800. 
[75] Hara, Y., Nikamoto, A., Kojima, T., Matsuboto, A. and 
Nakao, M. (1988) FEBS Lett. 238, 27-30. 
[76] Bucher, P. and Trifonov, E.N. (1986) Nucleic Acids Res. 14, 
10009-10020. 
[77] Nakamura, H., Okano, K., Aoki, V., Shimizu, H. and Naruto, 
M. (1987) Nucleic Acids Res. 15, 9601-9602. 
[78] Zenke, M., Grundstrom, T., Mattes, H., Wintzerith, M., 
Schatz, C., Wildernan, A. and Chambon, P. (1986) EMBO J. 
5, 387-397. 
[79] Maniatis, T., Goodbourn, S. and Fischer, J.A. (1987) Science 
236, 1237-1245. 
[80] Lo, C.S. and Edelman, I.S. (1976) J. Biol. Chem. 251, 
7834-7840. 
[81] Geering, K., Girardet, M., Bron, C., Kraehenbuhl, J.-P. and 
Rossier, B.C. (1982) J. Biol. Chem. 257, 10338-10343. 
[82] Tamkun, M.M. and Fambrough, D.M. (1986) J. Biol. Chem. 
261, 1009-1019. 
[83] Young, R.M., Shull, G.E. and Lingrel, J.B. (1987) J. Biol. 
Chem. 262, 4905-4910. 
[84] Martin-Vassallo, P., Dackowsky, W., Emanuel, J.R. and 
Levenson, R. (1989) J. Biol. Chem. 264, 4613-4618. 
[85] Okamoto, C., Reenstra, W.W., Li, W. and Forte, J.G. (1989) 
J. Cell. Biol. 107, 125a. 
[86] Ushkaryov, Yu.A., Monastyrskaya, G.S., Broude, N.E., 
Bessarab, D.A., Modyanov, N.N. and Sverdlov, E.D. (1989) 
FEBS Lett., in press. 
